Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia

BACKGROUND: Promising clinical and humanistic outcomes are associated with the use of new oral agents in the treatment of relapsing-remitting multiple sclerosis (RRMS). This is the first cost-effectiveness study comparing these medications in Saudi Arabia. OBJECTIVES: We aimed to compare the cost-ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaqa’aby, Mai F., Vaidya, Varun, Khreis, Noura, Al Khairallah, Thamer, Al-jedai, Ahmed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074120/
https://www.ncbi.nlm.nih.gov/pubmed/29229891
http://dx.doi.org/10.5144/0256-4947.2017.433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074120/
https://www.ncbi.nlm.nih.gov/pubmed/29229891
http://dx.doi.org/10.5144/0256-4947.2017.433

Ejemplares similares